Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/3/2025 | $56.00 | Equal Weight | Wells Fargo |
| 4/25/2025 | $55.00 | Buy → Hold | Canaccord Genuity |
| 11/22/2024 | $96.00 → $100.00 | Market Perform → Outperform | BMO Capital Markets |
| 12/6/2023 | $110.00 | Buy | Canaccord Genuity |
| 11/7/2023 | $72.00 | Sell | UBS |
| 9/18/2023 | $102.00 | Overweight | Wells Fargo |
| 6/1/2023 | $80.00 | Buy | UBS |
| 4/27/2023 | $109.00 → $66.00 | Buy → Underperform | BofA Securities |
8-K - ASGN Inc (0000890564) (Filer)
S-8 - ASGN Inc (0000890564) (Filer)
10-Q - ASGN Inc (0000890564) (Filer)
Wells Fargo initiated coverage of ASGN Incorporated with a rating of Equal Weight and set a new price target of $56.00
Canaccord Genuity downgraded ASGN Incorporated from Buy to Hold and set a new price target of $55.00
BMO Capital Markets upgraded ASGN Incorporated from Market Perform to Outperform and set a new price target of $100.00 from $96.00 previously
4 - ASGN Inc (0000890564) (Issuer)
3 - ASGN Inc (0000890564) (Issuer)
4 - ASGN Inc (0000890564) (Issuer)